Retour
Fourchette du Jour
8,74 €
9,08 €
Fourchette 52 Semaines
5,81 €
9,98 €
Volume
554 048
Moyenne 50J / 200J
8,36 €
/
7,36 €
Clôture Précédente
8,64 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 26,7 | 0,4 |
| P/B | 3,3 | 2,9 |
| ROE % | 13,7 | 3,7 |
| Net Margin % | 4,0 | 3,9 |
| Rev Growth 5Y % | 7,2 | 10,0 |
| D/E | 1,7 | 0,2 |
Objectif de Cours des Analystes
Hold
13,00 €
+44.4%
P/E Prévisionnel
12,0
BPA Prévisionnel
0,75 €
Croissance BPA (est.)
+0,0%
CA Est.
600 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,22 €
1,22 € – 1,22 €
|
790 M | 1 |
| FY2029 |
1,08 €
1,08 € – 1,08 €
|
740 M | 1 |
| FY2028 |
1,02 €
0,88 € – 1,16 €
|
690 M | 2 |
Points Clés
Revenue grew 7,15% annually over 5 years — modest growth
ROE of 13,69% — decent returns on equity
Generating 71,41M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,06%
Cash machine — converts 314,16% of earnings into free cash flow
Capital efficient — spends only 0,45% of revenue on capex
Croissance
Revenue Growth (5Y)
7,15%
Revenue (1Y)-0,91%
Earnings (1Y)N/A
FCF Growth (3Y)199,11%
Qualité
Return on Equity
13,69%
ROIC8,86%
Net Margin4,00%
Op. Margin10,31%
Sécurité
Debt / Equity
1,69
Current Ratio1,70
Interest Coverage2,21
Valorisation
P/E Ratio
26,67
P/B Ratio3,29
EV/EBITDA14,80
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,91% | Revenue Growth (3Y) | 5,30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7,15% | Earnings Growth (5Y) | 4,08% |
| Profitability | |||
| Revenue (TTM) | 568,09M | Net Income (TTM) | 22,73M |
| ROE | 13,69% | ROA | 3,33% |
| Gross Margin | 67,32% | Operating Margin | 10,31% |
| Net Margin | 4,00% | Free Cash Flow (TTM) | 71,41M |
| ROIC | 8,86% | FCF Growth (3Y) | 199,11% |
| Safety | |||
| Debt / Equity | 1,69 | Current Ratio | 1,70 |
| Interest Coverage | 2,21 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 26,67 | P/B Ratio | 3,29 |
| P/S Ratio | 1,07 | PEG Ratio | -0,13 |
| EV/EBITDA | 14,80 | Dividend Yield | 0,00% |
| Market Cap | 606,31M | Enterprise Value | 866,42M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 568,09M | 573,28M | 512,35M | 512,12M | 430,90M |
| Net Income | 22,73M | -33,54M | -156,23M | -158,70M | 19,38M |
| EPS (Diluted) | 0,33 | -0,52 | -2,49 | -2,59 | -0,15 |
| Gross Profit | 382,43M | 388,23M | 328,19M | 331,08M | 302,71M |
| Operating Income | 58,55M | -11,98M | -81,73M | -167,23M | 12,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 683,56M | 727,96M | 810,91M | 1,37B | 1,23B |
| Total Liabilities | 455,11M | 542,35M | 589,79M | 960,43M | 692,07M |
| Shareholders' Equity | 184,11M | 147,94M | 173,59M | 325,24M | 458,92M |
| Total Debt | 311,35M | 335,63M | 394,85M | 418,07M | 357,68M |
| Cash & Equivalents | 51,24M | 41,58M | 36,96M | 30,19M | 43,93M |
| Current Assets | 272,84M | 275,61M | 268,00M | 272,58M | 263,10M |
| Current Liabilities | 160,38M | 210,40M | 175,50M | 304,02M | 180,86M |